To include your compound in the COVID-19 Resource Center, submit it here.

Tacrolimus: Phase II data

Top-line data from an open-label Phase II trial in 58 patients showed that

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE